Lessons from #ACEP13 Day 3 - October 16th, 2013

(some of the many contributors to Wednesday’s #ACEP13 twitter feed – thank you!)

Day 3 by the Numbers

3,395 tweets

548 participants

3 million impressions

Categories (Storified tweets above – hover over photos to see text – at bottom of page, and here)

Stuff I learned:

ACEP is reconsidering the tPA policy, there will be a comment period (see Angela Gardner’s tweets)
A ton of great stuff from the Hof-Kata session.
Must work to reduce the risk of post-ROSC hyperoxia. In general, dial down FiO2 to 60% as soon as tolerated by pt. (keep pt sat around 94%, no need to get to 100%, may be harmful
Hold off on insulin in DKA until you check a K (and start fluid resuscitation)
There is now evidence for push dose pressors (citations on Storify)
Great review of IO’s (humeral allows for larger volumes, needs longer needle, etc)
MOPETT Trial discussion
How to make cornstarch based gel for US (thanks to APousson)
Review of mechanical ventilation settings
Benign coughs 2/2 URI’s may last around 18 days, back pain can linger 3 months…Must align patient expectations.
The huge of amount of $$$ journals make off of pharmaceutical industry requests for reprints.
Lack of evidence for Tamiflu
All sorts of SAH stuff…
And so much more…

A full transcript of yesterday’s tweets is available via Symplur at: http://bit.ly/19PkpJf Bodymender has also done it again. See his high-yield pearls at: http://storify.com/Bodymender_n_ED/acep13-day-3 One of the most important quotes:

Hoffman: “I do believe public health is part of our job, and advocacy part of our job” #acep13 — Policy Prescriptions (@PolicyRx) October 17, 2013

And, finally, an evidentiary moment :

Reader Interactions